PROGENITY, INC. Business Finance Contracts & Agreements
82 Contracts & Agreements
- Credit Agreements (6 contracts)
- Equity Distribution Agreements (1)
- Exchange Agreements (4)
- Indenture Agreements (6)
- Investor Rights Agreements (7)
- Note Agreements (5)
- Purchase Agreements (8)
- Registration Rights Agreements (3)
- Security Agreements (1)
- Stock Agreements (11)
- Term Sheets (1)
- Underwriting Agreements (3)
- Warrant Agreements (26)
- DIP Term Sheet (Filed With SEC on December 30, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 29, 2024)
- Form of October 2024 Private Placement Warrant (Filed With SEC on October 29, 2024)
- Form of Warrant Amendment, dated as of August 15, 2024, by and between the Company and the investors named therein (Filed With SEC on August 21, 2024)
- Form of Registration Rights Agreement, dated as of August 15, 2024, by and between the Company and the investors named therein (Filed With SEC on August 21, 2024)
- Form of Additional Warrant (Filed With SEC on August 21, 2024)
- Form of Initial Commitment Warrant (Filed With SEC on August 21, 2024)
- A&R Indenture, dated August 15, 2024, between the Company and GLAS Trust Company LLC, as trustee and collateral agent (Filed With SEC on August 21, 2024)
- Form of Note Exchange Agreement, dated August 12, 2024, between the Company and the holders named therein (Filed With SEC on August 12, 2024)
- Form of Note Purchase Agreement, dated August 12, 2024, between the Company and the purchasers named therein (Filed With SEC on August 12, 2024)
- Equity Distribution Agreement, dated July 1, 2024, by and between Biora Therapeutics, Inc., Canaccord Genuity LLC and H.C. Wainwright & Co., LLC (Filed With SEC on July 1, 2024)
- Form of Voting Agreement (attached as Exhibit D to the Form of Securities Purchase Agreement) (Filed With SEC on April 2, 2024)
- Form of March 2024 Private Placement Warrant (Filed With SEC on April 2, 2024)
- Second Supplemental Indenture, dated as of March 12, 2024, between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on April 1, 2024)
- First Supplemental Indenture, dated as of December 19, 2023, between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on April 1, 2024)
- Form of Registration Rights Agreement, to be dated as of the Closing Date, between the Company and the investor named therein (Filed With SEC on March 11, 2024)
- Form of Note Purchase Agreement, dated March 8, 2024, between the Company and the purchaser named therein (Filed With SEC on March 11, 2024)
- Form of Note Exchange Agreement, dated March 8, 2024, between the Company and the holder named therein (Filed With SEC on March 11, 2024)
- Form of March 2024 Warrant (Filed With SEC on March 11, 2024)
- Form of Supplemental Indenture, to be dated as of the Closing Date, between the Company, the guarantors party thereto and GLAS Trust Company LLC (Filed With SEC on March 11, 2024)
- Form of Registration Rights Agreement, to be dated as of the Closing Date, between the Company and the investors named therein (Filed With SEC on December 18, 2023)
- Form of Security Agreement, to be dated as of the Closing Date, between the Company, as issuer, subsidiaries of the Company, as guarantors, and GLAS Trust Company LLC, as... (Filed With SEC on December 18, 2023)
- Form of Note Purchase Agreement, dated December 18, 2023, between the Company and the purchasers named therein (Filed With SEC on December 18, 2023)
- Form of Note Exchange Agreement, dated December 18, 2023, between the Company and the holders named therein (Filed With SEC on December 18, 2023)
- Form of Additional Warrant (Filed With SEC on December 18, 2023)
- Form of Commitment Warrant (Filed With SEC on December 18, 2023)
- Form of Exchange Warrant (Filed With SEC on December 18, 2023)
- Indenture, to be dated as of the Closing Date, between the Company and GLAS Trust Company LLC (Filed With SEC on December 18, 2023)
- Purchase and Sale Agreement, dated October 6, 2023, by and among Biora Therapeutics, Inc. and Lynxdx, Inc (Filed With SEC on November 13, 2023)
- Form of October 2023 Private Placement Warrant (Filed With SEC on October 11, 2023)
- Convertible Notes Exchange Agreement for Common Stock and Warrants, dated September 18, 2023, by and among, the Company, Athyrium Opportunities III Acquisition LP and Athyrium... (Filed With SEC on September 19, 2023)
- Amendment No. 4 to Fourth Amended and Restated Investors Rights Agreement, dated as of September 18, 2023, by and among Biora Therapeutics, Inc., and certain of its stockholders (Filed With SEC on September 19, 2023)
- Form of September 2023 Warrant (Filed With SEC on September 19, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on September 19, 2023)
- Form of Warrant (Filed With SEC on June 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 14, 2023)
- Form of Amended Warrant ($2.84 warrants) (Filed With SEC on November 9, 2022)
- Form of Amended Warrant ($6.86 warrants) (Filed With SEC on November 9, 2022)
- Form of Warrant (Filed With SEC on November 9, 2022)
- Form of Securities Purchase Agreement, dated November 6, 2022, by and between the Company and the Purchasers signatory therein (Filed With SEC on November 9, 2022)
